🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-08-08
Trial ID
NCT05941585
Treatments Being Tested
Central nervous system (CNS) relapses of aggressive lymphomas are a rare bu...
Status
Unknown
Location
Charité Universitätsmedizin
Start Date
2007-10
Trial ID
NCT01148173
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
The purpose of this trial is to test the safety and tolerance of the combin...
Status
Terminated
Location
Neurologische Universitaetsklinik Bonn
Start Date
2012-03
Trial ID
NCT01563614
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
This is a single-arm, open-label clinical trial evaluating the safety and p...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-08
Trial ID
NCT07490288
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
Children's Hospital Los Angeles
Start Date
1997-02
Trial ID
NCT00003073
Treatments Being Tested
To confirm the efficacy of CPX-351 compared to 7+3 as first line therapy in...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2012-12-13
Trial ID
NCT01696084
Treatments Being Tested
This phase II trial studies the side effects and how well Vyxeos works in t...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center
Start Date
2021-01-29
Trial ID
NCT04049539
Treatments Being Tested